Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging

Background To investigate the ability of amide proton transfer (APT) weighted magnetic resonance imaging (MRI), arterial spin labeling (ASL), diffusion weighted imaging (DWI) and the combination for differentiating high-grade gliomas (HGGs) from low-grade gliomas (LGGs). Methods Twenty-seven patients including nine LGGs and eighteen HGGs underwent conventional, APT, ASL and DWI MRI with a 3.0-T MR scanner. Histogram analyses was performed and quantitative parameters including mean apparent diffusion coefficient (ADC mean), 20th-percentile ADC (ADC 20th), mean APT (APT mean), 90th-percentile APT (APT 90th), relative mean cerebral blood flow (rCBF mean) and relative 90th-percentile CBF (rCBF 90th) were compared between HGGs and LGGs. The diagnostic performance was evaluated with receiver operating characteristic (ROC) analysis of each parameter and their combination. Correlations were analyzed among the MRI parameters and Ki-67. Results The APT values were significantly higher in the HGGs compared to the LGGs ( p  <  0.005), whereas ADC values were significantly lower in HGGs than LGGs ( P  <  0.0001). The ADC 20th and APT mean had higher discrimination abilities compared with other single parameters, with the area under the ROC curve (AUC) of 0.877 and 0.840. Adding ADC parameter, the discrimination ability of APT and rCBF significantly improved. The ADC was negatively correlated with the APT and rCBF value, respectively, while APT value was positively correlated with rCBF value. Significant correlations between ADC values and Ki-67 were also observed. Conclusions APT and DWI are valuable in differentiating HGGs from LGGs. The combination of APT, DWI and ASL imaging could improve the ability for discriminating HGGs from LGGs.

[1]  Xuna Zhao,et al.  Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T , 2011, Magnetic resonance in medicine.

[2]  C. Metreweli,et al.  Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? , 2002, Clinical radiology.

[3]  C. Zimmer,et al.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.

[4]  Z. Wu,et al.  Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? , 2006, The British journal of radiology.

[5]  Hye-Young Heo,et al.  Applying amide proton transfer‐weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas , 2016, Journal of magnetic resonance imaging : JMRI.

[6]  Sumei Wang,et al.  Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging , 2015, Cancer Imaging.

[7]  Seth A. Smith,et al.  Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma , 2016, European Radiology.

[8]  Namkug Kim,et al.  Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. , 2013, Radiology.

[9]  Satoshi O. Suzuki,et al.  Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging , 2017, European Radiology.

[10]  S. Shibata,et al.  Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain , 2001, Neuroradiology.

[11]  L. Bozzao,et al.  Supratentorial diffuse astrocytic tumours: proposal of an MRI classification , 1997, European Radiology.

[12]  Jinyuan Zhou,et al.  MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast , 2010, NeuroImage.

[13]  N. Bulakbaşı,et al.  The Added Value of the Apparent Diffusion Coefficient Calculation to Magnetic Resonance Imaging in the Differentiation and Grading of Malignant Brain Tumors , 2004, Journal of computer assisted tomography.

[14]  Tsutomu Okada,et al.  Grading glial tumors with amide proton transfer MR imaging: different analytical approaches , 2015, Journal of Neuro-Oncology.

[15]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[16]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[17]  Jinyuan Zhou,et al.  Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume , 2017, European Radiology.

[18]  Ho Sung Kim,et al.  Histogram Analysis of Amide Proton Transfer Imaging to Identify Contrast-enhancing Low-Grade Brain Tumor That Mimics High-Grade Tumor: Increased Accuracy of MR Perfusion. , 2015, Radiology.

[19]  Huiguang He,et al.  The diagnostic value of high-frequency power-based diffusion-weighted imaging in prediction of neuroepithelial tumour grading , 2017, European Radiology.

[20]  Mitchel S Berger,et al.  Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. , 2007, Journal of neurosurgery.

[21]  Jinyuan Zhou,et al.  Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.

[22]  Jinyuan Zhou,et al.  Differentiating the histologic grades of gliomas preoperatively using amide proton transfer‐weighted (APTW) and intravoxel incoherent motion MRI , 2018, NMR in biomedicine.

[23]  Jinyuan Zhou,et al.  Amide proton transfer (APT) contrast for imaging of brain tumors , 2003, Magnetic resonance in medicine.

[24]  J. Detre,et al.  Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla , 2005, Journal of magnetic resonance imaging : JMRI.

[25]  Susan M. Chang,et al.  Recent advances in therapy for glioblastoma. , 2010, Archives of neurology.

[26]  Koji Yamashita,et al.  Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. , 2014, Neuro-oncology.

[27]  B. K. Ojha,et al.  Comparative Evaluation of 3-Dimensional Pseudocontinuous Arterial Spin Labeling With Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Human Glioma , 2013, Journal of computer assisted tomography.

[28]  Jinyuan Zhou,et al.  Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts , 2008, NMR in biomedicine.

[29]  Jinyuan Zhou,et al.  Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.

[30]  Zhiqiang Zhang,et al.  Comparison of Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging and Arterial Spin Labeling MR Imaging in Gliomas , 2015, BioMed research international.

[31]  Wen Wang,et al.  Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial , 2017, BMC Medical Imaging.

[32]  L. S. Adelman Grading astrocytomas. , 1994, Neurosurgery clinics of North America.

[33]  Peng Cao,et al.  Textural features of dynamic contrast‐enhanced MRI derived model‐free and model‐based parameter maps in glioma grading , 2018, Journal of magnetic resonance imaging : JMRI.

[34]  Jin-Suh Kim,et al.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. , 2002, AJR. American journal of roentgenology.

[35]  Leonard Sunwoo,et al.  Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS‐MLPA in patients with glioblastoma multiforme , 2013, Journal of magnetic resonance imaging : JMRI.

[36]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[37]  Danny J. J. Wang,et al.  Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging , 2015, European Radiology.

[38]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.